Article Information
History
- January 11, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Author Information
- Sara Y. Tartof1,2,‡,
- Fagen Xie1,
- Ruchi Yadav3,
- Karen J. Wernli2,4,
- Emily T. Martin5,
- Edward A. Belongia6,
- Manjusha Gaglani7,8,
- Richard K. Zimmerman9,
- H. Keipp Talbot10,
- Natalie Thornburg3,
- Brendan Flannery3,
- Jessie R. Chung11,†,
- US Flu VE Network Investigators*
- 1Kaiser Permanente Southern California, Department of Research & Evaluation
- 2Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA USA
- 3Centers for Disease Control and Prevention, Atlanta, GA, USA
- 4Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA
- 5University of Michigan School of Public Health, Ann Arbor, MI, USA
- 6Marshfield Clinic Research Institute, Marshfield, WI, USA
- 7Baylor Scott & White Health, Temple, TX, USA
- 8Texas A&M University College of Medicine, Temple, TX, USA
- 9University of Pittsburgh, Pittsburgh, PA, USA
- 10Vanderbilt University Medical Center, Nashville, TN, USA
- 11Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop 24/7, Atlanta, Georgia, 30329
- ↵†Corresponding author:
Jessie R. Chung, Influenza Division, Centers for Disease Control and Prevention, 1600 Clifton Rd NE, Mailstop 24/7, Atlanta, Georgia, 30329 (jchung{at}cdc.gov, 404-639-2696). - ↵‡Alternative corresponding author/media inquiries:
Dr. Sara Y. Tartof, Kaiser Permanente Research, 100 S. Los Robles, 2nd Floor, Pasadena, California, 91101 (sara.y.tartof{at}kp.org, 626-564-3001)
Posted January 11, 2023.
Prior SARS-CoV-2 Infection and COVID-19 Vaccine Effectiveness against Outpatient Illness during Widespread Circulation of SARS-CoV-2 Omicron Variant, US Flu VE Network
